STUDY OF EFFECT OF GLYCEMIC CONTROL IN CKD DIABETIC PATIENTS AND THEIR RELATION TO HYPOGLYCEMIA C-PEPTIDE AND ISLET ANTIBODIES | ||
| ALEXMED ePosters | ||
| Article 1, Volume 6, Issue 1, January 2024, Pages 30-31 | ||
| Document Type: Preliminary preprint short reports of original research | ||
| DOI: 10.21608/alexpo.2024.265209.1780 | ||
| Authors | ||
| Magdy Helmi Megalla1; Mona Wagdy Helmy2; Mohamed Said Abd Elsalam1; Mohamed Said Koheya* 3 | ||
| 1Department of Internal Medicine, Faculty of Medicine, Alexandria University | ||
| 2Department of Clinical and Chemical Pathology, Faculty of Medicine Alexandria University | ||
| 3Department of Internal Medicine , Faculty of Medicine , Alexandria University | ||
| Abstract | ||
| Diabetes mellitus is a major public health issue with an increasing prevalence worldwide. In Egypt, DM is the leading cause of chronic kidney failure. Classification: type I DM, type II DM, Gestational DM, MoDY, LADA. Complication: Diabetic nephropathy is significant cause of morbidity and mortality in DM patients with progression to ESRD. Figure (1): NICE/KDIGO classification of CKD using eGFR and ACR categories. Hypoglycemic Hypoglycemic is an essential and frequent adverse effect of glycemic control, as it causes significant morbidity and mortality. A plasma glucose concentration of | ||
| Keywords | ||
| CKD; HYPOGLYCEMIA; C-PEPTIDE | ||
|
Supplementary Files
|
||
|
Statistics Article View: 50 |
||
